Device / Technology News

RSS

OMT, a viable option for treating back pain in the third trimester of pregnancy

For many pregnant women, it's inevitable. As their pregnancy progresses, tasks that involve the low back often get more difficult. It is harder to bend over, lift, sit or walk for long periods of time, and back pain increases. Treating back pain, and improving daily function relative to tasks that involve the low back is a challenge because pregnant women are limited to treatments that will not create problems for their developing baby.

29 Jan 2010

CAMH signs licensing agreement to develop and market genetic test for degenerative muscle disorder

The Centre for Addiction and Mental Health (CAMH) has signed a licensing agreement with a Massachusetts firm to develop and market an innovative genetic test for a recently identified degenerative muscle disorder. The disorder tends to strike adults in their early 30s.

From Thermo Fisher Scientific Inc. 29 Jan 2010

AHRQ and American College Of Cardiology team up to study risks and benefits of ICDs

A $3.5 million research project that will study the long-term benefits and risks of implantable cardioverter defibrillators (ICDs) in patients at risk of death from ventricular fibrillation will be supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology, the two groups announced today.

29 Jan 2010

Quintiles announces strategic alliance with Movetis NV for commercialization of Resolor

Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.

29 Jan 2010

RTI Biologics donates Matrix HD to treat eight-year-old with recessive dystrophic EB

RTI Biologics Inc. (RTI), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated a sterilized dermis allograft, Matrix HD™, to treat an eight-year old patient with a rare skin disease called recessive dystrophic epidermolysis bullosa (EB).

29 Jan 2010

Tufts CSDD announces the launch of new website

The Tufts Center for the Study of Drug Development, the world's leading, independent authority on the nature and pace of pharmaceutical and biotech drug development, today announced the launch of its new website that makes it easier for industry professionals and others to research critical drug development issues.

29 Jan 2010

VisEn Medical acquires Bayer Schering Pharma AG's fluorescence agent intellectual property portfolios

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today that it has acquired the fluorescence imaging agent intellectual property portfolios and related technology platforms from Bayer Schering Pharma AG, Germany.

29 Jan 2010

iPierian receives UK patent for induced pluripotent stem cell technology

iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced that the Intellectual Property Office in the United Kingdom has issued a Notification of Grant to iPierian for UK patent No. GB2450603, its first patent related to induced pluripotent stem cell (iPSC) technology.

29 Jan 2010

NovaSom Diagnostic System approved for diagnostic evaluation of adults with OSA

Some 18-20 million Americans are at risk for Obstructive Sleep Apnea (OSA) and of those, only 5 to 10 percent have been diagnosed. Studies prove that fatality is a major risk of undiagnosed and untreated OSA; however, once detected, OSA can be readily and successfully treated.

29 Jan 2010

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Life Technologies Corporation and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite’s new facility in Northern Virginia.

28 Jan 2010

Tornier and LifeCell commence enrollment in Conexa Reconstructive Tissue Matrix clinical trial

Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.

28 Jan 2010

Innovative cardiac scanner allows early detection of heart conditions

The portable magnetometer is being developed at the University of Leeds, with funding from the Engineering and Physical Sciences Research Council (EPSRC) playing a key role.

28 Jan 2010

Life Spine's DYNA-LINK Spinal System and PRESIDIO Spinal Plating System receive FDA marketing clearance

Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to both the DYNA-LINK Spinal System and the PRESIDIO Spinal Plating System.

28 Jan 2010

EnteroMedics to submit an IDE application for next-generation Maestro RC System

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company’s EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.

28 Jan 2010

ZOLL Medical's LifeVest Wearable Defibrillator named one of top five innovative medical devices of 2009

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.

28 Jan 2010

Cenduit announces strategic business alliance with invivodata

Cenduit, LLC, and invivodata, inc., today announce a strategic business alliance to further improve clinical trial efficiencies by adding the scientific and operational benefits of invivodata’s electronic Patient Reported Outcomes (ePRO) solutions to the proven efficiencies of Cenduit‘s Interactive Response Technology solution (IRT).

28 Jan 2010

ACM Global Central Laboratory launches enhanced version of its proprietary LabStar system

ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, has launched an enhanced version of its proprietary LabStarSM system, which captures all clinical trial testing data in a single location for easy access and comprehensive reporting.

28 Jan 2010

ZOLL Medical, HealthTrust Purchasing Group enter into purchasing agreement

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that HealthTrust Purchasing Group, LP (HealthTrust), a leading healthcare group purchasing organization (GPO), has entered into a purchasing agreement with ZOLL for its therapeutic temperature management equipment.

28 Jan 2010

Christiana Care Health System introduces COPE technology for common diagnoses

Christiana Care Health System is taking a giant leap forward toward a comprehensive Electronic Health Record with the launch of Computerized Provider Order Entry (CPOE), technology that makes it easier, more efficient and safer for doctors to order tests and medications.

28 Jan 2010

PHT announces enhanced StudyWorks portal for clinical trial management

PHT Corporation continues to drive the ePRO (electronic patient reported outcome) industry forward. The company today announced an enhanced StudyWorks™ portal that offers study sponsors an unprecedented level of management and logistical control over their clinical trials. PHT is the leading provider of ePRO solutions used in more than 400 clinical trials worldwide.

28 Jan 2010

Device / Technology News

OMT, a viable option for treating back pain in the third trimester of pregnancy

CAMH signs licensing agreement to develop and market genetic test for degenerative muscle disorder

AHRQ and American College Of Cardiology team up to study risks and benefits of ICDs

Quintiles announces strategic alliance with Movetis NV for commercialization of Resolor

RTI Biologics donates Matrix HD to treat eight-year-old with recessive dystrophic EB

Tufts CSDD announces the launch of new website

VisEn Medical acquires Bayer Schering Pharma AG's fluorescence agent intellectual property portfolios

iPierian receives UK patent for induced pluripotent stem cell technology

NovaSom Diagnostic System approved for diagnostic evaluation of adults with OSA

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Tornier and LifeCell commence enrollment in Conexa Reconstructive Tissue Matrix clinical trial

Innovative cardiac scanner allows early detection of heart conditions

Life Spine's DYNA-LINK Spinal System and PRESIDIO Spinal Plating System receive FDA marketing clearance

EnteroMedics to submit an IDE application for next-generation Maestro RC System

ZOLL Medical's LifeVest Wearable Defibrillator named one of top five innovative medical devices of 2009

Cenduit announces strategic business alliance with invivodata

ACM Global Central Laboratory launches enhanced version of its proprietary LabStar system

ZOLL Medical, HealthTrust Purchasing Group enter into purchasing agreement

Christiana Care Health System introduces COPE technology for common diagnoses

PHT announces enhanced StudyWorks portal for clinical trial management

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News